statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FibroGen, Acorda Therapeutics, Enveric Biosciences among healthcare movers...

FibroGen, Acorda Therapeutics, Enveric Biosciences among healthcare movers

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
The post ENVB...

ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q4 2023

Enveric Biosciences, Inc. (NASDAQ:ENVB - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling...

Enveric Biosciences, Inc. (NASDAQ:ENVB) Short Interest Up 58.1% in March

Enveric Biosciences, Inc. (NASDAQ:ENVB - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 150,400...

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of...

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease

Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Enveric Biosciences to sell 228,690 shares at $1.41 in direct offering

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds

EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company was founded on February 28, 1994 and is headquartered in Naples, FL.

Volume	210,159.00
52-Wk High	$6.98
52-Wk Low	$0.649

ENVB Enveric Biosciences Inc

About

Feed

News

Sentiment

Fundamentals